Primary gastric fundus tuberculosis in immunocompetent patient: a case report and literature review.
We report on a 29-year-old Pakistani man who presented to the clinic with epigastric pain, of one-month duration. He did not report fever, cough, vomiting blood, passing black stools, loss of appetite or diarrhea. However, he had lost 7 kg since his symptoms had begun. Clinical examination was unremarkable. Laboratory results were within normal limits. An abdominal CT scan showed a mass with enhancement in the stomach. Gastric endoscopy revealed an ulcerative mass in the fundus. An endoscopic-biopsy specimen revealed caseating granulomas with acid-fast bacilli. The patient was diagnosed to have primary gastric tuberculosis, and antituberculous medications were initiated. Cultures of the gastric mass subsequently grew Mycobacterium tuberculosis sensitive to isoniazid and rifampcin. Follow-up after six months showed a good response to treatment; an upper gastrointestinal tract endoscopy after six months was normal.
Khan
Fahmi Yousef
FY
Department of Medicine, Hamad General hospital, Doha-Qatar. fakhanqal@yahoo.co.uk
AlAni
Ahmed
A
Al-Rikabi
Ammar
A
Mizrakhshi
A
A
Osman
Mohamed El-Mudathir
Mel-M
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D005748:Gastric Fundus / Q000382:microbiology; D005773:Gastroscopy; D006801:Humans; D007121:Immunocompetence; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D013272:Stomach Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D014057:Tomography, X-Ray Computed; D014385:Tuberculosis, Gastrointestinal / Q000175:diagnosis* / Q000188:drug therapy
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin